Stents

Abbott announced that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1. Absorb GT1 combines a fully dissolving stent with a next-generation delivery catheter to help doctors treat people with heart d...

BEST trial, ACC.15,

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study...

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment fol...

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioresorbable vascular scaffold (BVS) is more cost effective and offers a higher quality of life than a best-in-class, permanent,...

Amaranth Medical, Fortitude BRS, MEND-II, RENASCENT, EuroPCR 2015
Amaranth Medical announced plans to report clinical results from the company's ongoing trial of its second-generation Fortitude sirolimus-eluting bioresorbable...
Abbott, Absorb, dissolving stent, resorbable, CE Mark, Europe
Abbott announced that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1. Absorb GT1 combines a fully dissolving...
Boston Scientific, investors, cardiology, growth, expansion
Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth strategies at a meeting with the investment community May...
Boston Scientific, Eluvia, MAJESTIC trial, vascular stent, PAD
A key trial evaluating the Boston Scientific Eluvia drug-eluting vascular stent system met its primary endpoint, with more than 94 percent of the lesions...
The Abbott family of Xience everolimus-eluting coronary stents—including the Xience V, Xience nano, Xience Prime, Xience Xpedition, and
MicroVention Inc.’s Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.) is a stent and delivery system used to...
Boston Scientific received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system, the...

Articles

BEST Trial
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared...
Medtronic, Drug Filled Stent, clinical trial, ACC
Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of...
Tryton Side Branch Stent, Pivotal IDE, bifurcation stent, bifurcation stent
Tryton Medical Inc. announced that results from the company’s pivotal clinical trial for the Tryton Side Branch Stent were published in the Journal of the...
A study being presented at the Society of Interventional Radiology’s annual scientific meeting says 3-D printing could become a powerful tool in customizing...

Video Center

The Heart Rhythm Society’s 36th Annual Scientific Sessions, May 13-16, 2015 in Boston, will offer...
1 week 3 days ago
U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
4 weeks 11 hours ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
8 weeks 12 hours ago
The webinar Maximize Your Clinical Imaging With a VNA Strategy will explain the changing face of medical imaging and data, and the challenges to...
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...